-
Mashup Score: 1
SELECT-MDS-1 will be discontinued after failing to meet its primary end point of improved CR rates with tamibarotene/azacitidine in high-risk, RARA+ MDS.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3Sesión 14 noviembre 2024 - 2 hour(s) ago
Bienvenida y presentación Dra. Maria Saigí 17.05 – 17.25 h Evidencia clínica de las estrategias basadas en IT en CPNCP Dr. Sviatoslav Chekhun 17.25 – 17.45 h Mecanismos de resistencia a la IT en CPNCP Dra. Laura Puntí Con colaboración de la Dra. Roser Velasco y Dra. Samanta Aso Conclusiones y Take home messages Dra. Maria Saigí Unidad de Tumores Torácicos, Servicio de Oncología Médica; Laboratorio de Genómica Traslacional
Source: www.lungyoungconnection.comCategories: General Medicine News, Oncologists1Tweet-
RT @MariaSaigi: 🗓️Propera sessió LYC 🔜28 Novembre a ICO Badalona. Us hi esperem!!🧬🫁 Inscripcions: https://t.co/86CQcF02nx https://t.co/8AQl…
-
-
Mashup Score: 0Momelotinib Wins Canadian Approval for Myelofibrosis With Anemia - 2 hour(s) ago
Health Canada has approved momelotinib for the treatment of splenomegaly and/or disease-related symptoms in myelofibrosis with moderate-to-severe anemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Momelotinib Wins Canadian Approval for Myelofibrosis With Anemia #mpnsm #oncology https://t.co/LLD7HVjwQE
-
-
Mashup Score: 3Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers - 3 hour(s) ago
Sacituzumab tirumotecan monotherapy demonstrated antitumor activity with a manageable safety profile in previously treated endometrial and ovarian cancers.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers @myESMO #ESMO24 #gynsm #ovca #oncology https://t.co/dExp7EVjQO
-
-
Mashup Score: 0Immunotherapy May Be Underused in Endometrial Cancer - 4 hour(s) ago
Suboptimal rates of dMMR testing and immunotherapy use suggest “a need for ongoing clinician and patient education, given the survival benefit of immunotherapy in recurrent endometrial cancer,” researchers concluded.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Immunotherapy and testing for mismatch repair deficiency may be underused in patients with #endometrialcancer in the United States, researchers say. Reported in @AJOG_thegray. https://t.co/Aot7gFgwN7 #gyncsm
-
-
Mashup Score: 1‘We deserve a say’: Medical residents in Rhode Island push to unionize - The Boston Globe - 4 hour(s) ago
Rhode Island medical residents caRhode Island medical residents campaign for unionization as costs rise, citing inadequate pay and a lack of support for well-being amid a physician shortage in the statempaign for unionization as costs rise, citing inadequate pay and support for well-being amid a physician shortage.
Source: www.bostonglobe.comCategories: General Medicine News, Oncologists1Tweet-
‘We deserve a say’: Medical residents in Rhode Island push to unionize Rhode Island medical residents campaign for unionization as costs rise, citing inadequate pay and a lack of support for well-being amid a physician shortage in the state. https://t.co/6s8zuuZRLX
-
-
Mashup Score: 2Brown University transfers 255 acres in Bristol, R.I., to the Pokanoket Indian tribe: ‘We are the original stewards’ - The Boston Globe - 4 hour(s) ago
“We are not talking about a land acknowledgment or cultural appreciation,” lawyer Taino Palermo said. “They have set a precedent to show other institutions they can do this.”
Source: www.bostonglobe.comCategories: General Medicine News, Oncologists1Tweet-
Leading the Ivy’s by a huge example in Rhode Island👇 Brown University transfers 255 acres in Bristol, R.I., to the Pokanoket Indian tribe: ‘We are the original stewards’ https://t.co/oUJYcd8Nvt
-
-
Mashup Score: 0
IBI354 favorable safety and efficacy in patients with advanced HER2-positive and HER2-low breast cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
IBI354 Shows Efficacy and Safety in HER2+ and HER2-Low Advanced Breast Cancer @myESMO #ESMO2024 #bcsm #oncology https://t.co/F6l7gHDiDN
-
-
Mashup Score: 0ChatGPT Has Promise as a Guide for Developing Consistent Nursing Care Plans - Oncology Nurse Advisor - 6 hour(s) ago
Researchers created a framework and targeted questions to prompt ChatGPT to generate nursing care plans, comparing them with plans generated by nurses.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
#AI is increasingly being integrated into health care, and ChatGPT has promise as a tool for generating nursing #careplans when used with carefully guided prompts. Published in @AMIAinformatics. https://t.co/zKu7BegFQx
-
-
Mashup Score: 0With ACA subsidies set to expire in 2025, millions of Americans stand to lose health insurance - 6 hour(s) ago
Allowing enhanced subsidies for health insurance bought through ACA marketplaces to expire would cause premiums to soar, experts warn.
Source: www.cbsnews.comCategories: General Medicine News, Oncologists1Tweet-
Hearing buzz in the news about "ACA subsidies" or "enhanced subsidies?" Learn more about what they are, who is eligible, why they may be at risk, and what it all means for patients and consumers ⬇️ https://t.co/O4Al7kGtUH
-
Tamibarotene Plus Azacitidine Fails to Improve CR Rates in High-Risk, RARA+ #MDS https://t.co/oBBRXqU9cs